Fast Track to IVF. Objectives
|
|
|
- Janel Nicholson
- 9 years ago
- Views:
Transcription
1 Disclosure statement: Richard H. Reindollar, M.D. has no relevant financial relationships with any manufacturers of pharmaceuticals, laboratory supplies, or medical devices. Fast Track to IVF Richard H. Reindollar, M.D. Professor and Chair, Department of Obstetrics and Gynecology Dartmouth Medical School Dartmouth-Hitchcock Medical Center Objectives At the conclusion of this presentation the participant will: 1.Understand the rationale for a fast track approach for women with UI under and over age 40; 2.Discuss advantages and limitations for initiating treatment with clomiphene/iui in younger women; and 3.Consider why expectant management may or may not be reasonable.
2 Management of Unexplained Infertility Observation (+/-) Clomiphene/IUI (+/-) Gonadotropins/IUI (+/-) IVF Fast Track To IVF Observation? Clomiphene/IUI? Gonadotropins/IUI? IVF Fast Track to IVF: What Is It? (Based on FASTT Trial and Preliminary Data of FORT-T Trial) When couples meet the definition of infertility: For couples, women < 40 years: skip observation and gonadotropin/iui, after CC/IUI proceed to IVF (FASTT Trial) For couples, women > 38 years: immediate IVF (FORT-T Trial)
3 Two Large NIH sponsored Infertility Trials The Fast Track and Standard Treatment (FASTT) Trial NIH/NICHD R01 HD38561* The Forty and Over Infertility Treatment Trial (FORT-T) NIH/NICHD R01 HD (preliminary results) * Reindollar et al. Fertil Steril (3): Reindollar et al. Fertil Steril (3): p. S1. Study Characteristics Treatment Naive Met definition of unexplained infertility (FASTT, 1 year; FORT-T, 6 months) Age FASTT: < 40 th birthday, (mean age 33 yrs); FORT-T: 38 yr 43 rd birthday, (mean age 40.3 yrs) Normal ovarian reserve before and during trials: (FSH < 15 miu/ml, E2 < 100 pg/ml; FASTT CD 3, FORT-T CCT) Fast Track for Couples, female p, partner < 40 years
4 The FASTT Trial Hypothesis For couples with unexplained infertility, the female partner < 40 years, an accelerated track to IVF (omitting FSH/IUI) will result in a shorter time to pregnancy and at an estimated cost savings compared to conventional care. Treatment Arms Conventional Clomiphene 100 mg x 5 days/ 1 IUI* x 3 cycles 150 FSH IU x 5 days/ 1 IUI each cycle x 3 cycles Fast Track Clomiphene 100 mg x 5 days/ 1 IUI* x 3 cycles IVF x 6 cycles (Maximum 4 fresh cycles) IVF x 6 cycles (Maximum 4 fresh cycles) *LH Kit, US backup Clomiphene/IUI: Why Use OI/IUI At All? Computer simulation demonstrated no difference Computer simulation demonstrated no difference in cost for immediate IVF
5 Results FASTT CONSORT Flow Diagram Preliminary Screen for Eligibility n = 10,188 Randomized, n = 503 9/2001 8/2005 Conventional Protocol, n = 247 Fast-track to IVF Protocol, n = 256 Initiated Treatment Protocol, n = 243 Initiated Treatment Protocol, n = 250 Follow-up Per Protocol, n = 212 Follow-up Per Protocol, n = 236 Analyzed, n = 247 Analyzed, n = 256 Cycle Characteristics Conventional Fast Track Total Patients Randomized Patients With 1 Cycle 243 (98) 250 (98) 493 (98) Total CC/IUI Cycles Total FSH/IUI Cycles 439 Total IVF Cycles [Incl. Thaw Cycles] 261 [32] 361 [29] 622 [61] Total Cycles * NOTE 337 FEWER CYCLES IN FAST TRACK COMPARED TO CONVENTIONAL ARM
6 Sustained Pregnancy Rates Per Couple N pregnant couples (% pregnant) Conventional Fast Track All N/ total * (%) CC 45 (19) 53 (22) 98/475 (21) FSH 43 (25) - 43/169 (25) IVF 73 (66) 118 (69) 191/283 (68) Subtotal 161 (66) 171 (68) 332/493 (67) CIP 24 (10) 28 (11) 52/503 (10) Total 185 (75) 199 (78) 384/503 (76) * Total couples undergoing treatment; Cycle Independent Pregnancies Pregnancy Rates Per Treatment Cycle Initiated Rx (N cycles) CC/IUI (N = 1,294) FSH/IUI (N = 439) IVF (N = 622) Conventional Fast Track All All Sustained All Sustained All Sustained 55 (8.5) 45 (7.0) 68 (10.5) 53 (8.2) 123 (9.5) 98 (7.6) 50 (11.4) 43 (9.8) (11.4) 43 (9.8) 95 (36.4) 73 (28.0) 145 (40.2) 118 (32.7) 240 (38.6) 191 (30.7) Cumulative Incidence of Pregnancy HR=1.40 (95% CI ) P=0.03 Fast Track (n=256) median time to pregnancy 8 mo. Conventional (n=247) median time to pregnancy 11 mo. (Analysis using piecewise Cox proportional hazards model)
7 Total Charges Per Delivery Includes outpatient, inpatient, ER, and medication charges for women, and infant inpatient charges obtained from Insurance Companies. Arm Couples with a Couples Sum Total live birth delivery Charge Per N* Charges Delivery N Conventional 215 $9,424, $71,399 Fast Track 233 $9,606, $61,553 * Insurance data available for 448 (89%) of 503 couples Multiple Births of Sustained Pregnancies Conventional Fast Track CC FSH IVF Total CC IVF Total Twins 5(11) 7 (16)* 21 (29) 37 (20) 3(6) 37 (31) 42 (21) Triplets 0 1 (+1)* 0 1 (+1)* > Total 5 (11) 8 (19) 21 (29) 38 (21) 4 (8) 39 (33) 45 (22) * Includes 1 reduced from triplets; includes cycle independent (CIP) Unknown multiple status for 5 CIP and 1 IVF ongoing pregnancies Conclusions Gonadotropin /IUI treatment does not add value to a contemporary treatment paradigm An accelerated approach to IVF (that eliminates FSH/IUI but starts with CC/IUI) results in an equivalent percentage of pregnancies with: a 40% increased rate of pregnancy (between 3 and 11 months of treatment) that is statistically significant; fewer treatment cycles; and, at an estimated lower cost. IVF would have to cost $17,749 for conventional treatment to have a lower cost per delivery than accelerated therapy
8 Fast Track for Couples, female partner < 40 years Clomiphene/IUI (~ 3 cycles) IVF Clomiphene/IUI: Why Include It? Computer simulation demonstrated no difference in cost for immediate IVF Clomiphene / IUI (with normal stimulation and no cancellation of cycles) allows the most fertile couples with the highest chance for multiples to become pregnant with a treatment that has a low chance for multiples before IVF Fast Track for Couples, female partner > 38 years (Preliminary Data of FORT-T Trial)
9 The FORT-T Trial Hypothesis Immediate IVF is a more effective treatment strategy for reproductively older women who demonstrate a reasonable chance for success than are treatments that begin with superovulation/iui. Treatment Arms *LH Kit, US unless they fail to demonstrate a reasonable chance for success: 2 cycles cancelled or for which embryo criteria not met FORT-T Consort Flow Diagram
10 Cycle Characteristics CC/IUI ARM FSH/IUI ARM IVF ARM Total Patients Randomized Patients With 1 Cycle 45 (88.2) 48 (92.3) 47 (92.2) 140 CC/IUI Cycles (17.9) FSH/IUI Cycles (18.9) 1 st 2 IVF Cycles (17.5) Total IVF Cycles [Incl. Thaw Cycles] (63.2) Total Cycles * 487 * Represents 36% fewer cycles than in either of the 2 arms Clinical And Live Born Pregnancy Rates Per Treatment Cycle Initiated 1 st 2 Cycles/Arm N pregnant couples (% pregnant) Clinical Live Born CC/IUI FSH/IUI IVF (n=87 cycles) (n=91 cycles) (n=85 cycles) 6 (6.9)* 7 (7.7)* 21 (24.7)* 13 (7.3)** 21 (24.7)** 3(3.4) 6 (6.6) 13(15.3) 9 (5.1) 13 (15.3) *p=0.004 ; ** p= p=0.03; p=0.017 Clinical And Live Born Pregnancy Rates Per Couple 1 st 2 Cycles/Arm N pregnant couples (% pregnant) CC/IUI FSH/IUI IVF (n=51) (n=52) (n=51) Clinical 6 (11.7)* 7 (13.5)* 21 (41.2)* 13 (12.6)** 21 (41.2)** Live Born 3 (5.9) 6 (11.5) 13 (25.5) 9 (8.7) 13 (25.5) *p=0.002; **p<0.001 p=0.02; p=0.01
11 Live Born Pregnancy Rates Per Couple All Cycles N pregnant couples (% pregnant) CC/IUI (n=51) FSH/IUI (n=52) IVF (n=51) All (n=154) CC 3 (5.9) 3 (1.9) FSH 6 (11.5) 6 (3.9) IVF 15 (29.4) 15 (28.8) 18 (35.3) 48 (31.2) Subtotal 18 (35.2) 21 (40.4) 18 (35.3) 57 (37.0) CIP 7 (13.7) 1 (1.9) 6 (11.8) 14 (9.1) Total 25 (49.0) 22 (42.3) 24 (47.1) 71 (46.1) Cycle Independent Pregnancies in Arm Note: 83% of CC/IUI, 71% of FSH/IUI and 84% of all RX related pregnancies were from IVF. Average Number of Rx Cycles Per Live Born Pregnancy (LB) Per Arm Rx Related LB All LB (Inc CIP) CC/IUI Arm FSH/IUI Arm Immediate IVF Arm 34±1 3.4±1.5* 5*(18 LB) 33±1 3.3±1.9* 9*(21 LB) 19±0 1.9±0.8* 8*(18 LB) (3,3,4) (2,3,4) (1,2,3) 2.7±1.9** (25 LB) (1,3,4) 3.1±2.0** (22 LB) 1.8±1.1** (24 LB) (2,3,4) (1,2,3) (25% le, 50% le, 75% le); * p=0.004; ** p=0.03 Randomization Arms Multiple Births of Live Born Pregnancies Treatment Cycles Clinical Pregnancies Live Birth Pregnancies Multiples CC/IUI First FSH/IUI randomized treatment IVF cycles * Note: all multiples are twins except one set (*) of IVF live birth triplets Addi onal independent mul ple birth prior to ini a ng randomized treatment (not counted here) Total Multiples / Live Births 5 /22 (22.7) All Arms Subsequent IVF treatment /35 (20.0) cycles Total (21.1)
12 Conclusions For treatment naïve couples who present with unexplained infertility at the end of reproductive years and who demonstrate a reasonable chance for success: Beginning treatment with immediate IVF, compared to initial treatments of SO/IUI, results in a significantly higher number of live born infants and with significantly more couples pregnant, during the initial cycles of treatment. Couples who begin treatment with SO/IUI and then, if not pregnant, proceed through an appropriate number of IVF cycles will have a similar live born pregnancy rate compared to couples whose treatment was only IVF, but- will go through significantly more treatment cycles, and the majority of their infants will be conceived through IVF. Immediate IVF is the most effective treatment for couples, the female partner at the end of reproductive years, who demonstrate a reasonable chance for success. Fast Track for Couples, female partner > 38 years Immediate IVF
13 Fast Track < 40 Fast Track > 38 Observation Clomiphene/IUI Immediate IVF Gonadotropins/IUI IVF Reindollar et al. Fertil Steril (3): Reindollar et al. Fertil Steril (3): p. S1. Questions to be Addressed Why not observation first? Why clomiphene/iui in younger couples? Why Exclude Observation? Clomiphene/IUI success in FASTT > reported success from no RX 7.6% vs. 2 4% (OPR vs. PR) Studies with observation arms, nearly all European, are mostly designed such that effectiveness of Rx is limited: COH not to be of significant influence.patients are stimulated rather mildly and mono or bifollicular cycles are quite common (Custers et al. Hum Reprod. 2008;23:885) Rx cycles are often cancelled (more chance for pregnancy in control cycles) The standard of care in US has moved beyond equipoise For the older patients, waiting may prevent any pregnancy the average age of the last pregnancy is just before 41 st birthday.
14 References 1. Reindollar et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertility and Sterility, (3): Reindollar et al. A randomized clinical trial to determine optimal infertility therapy in couples when the female partner is years: preliminary results from the forty and over infertility treatment trial (FORT-T). Fertility and Sterility, (3):S1. 3. Guzick et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network. N Engl J Med, (3): References (cont.) 4. Custers et al. Intrauterine insemination: how many cycles should we perform? Hum Reprod, (4): Steures et al. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised d clinical i l trial. Lancet, (9531):
Welcome to chapter 2. The following chapter is called "Indications For IVF". The author is Dr Kamini A. Rao.
Welcome to chapter 2. The following chapter is called "Indications For IVF". The author is Dr Kamini A. Rao. The indications for an IVF treatment have increased since the birth of the first IVF baby. The
Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register
1 Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register Joanne Gunby, M.Sc. CARTR Co-ordinator Email: [email protected] Supported by the IVF Directors Group of
European IVF Monitoring (EIM) Year: 2008
European IVF Monitoring (EIM) Year: 2008 Name of country POLAND Name and full address of contact person. professor Rafal Kurzawa MD PhD Fertility and Sterility Special Interest Group Polish Gynaecological
Clinical Reference Group Quality & Safety Committee Governing Body. Policy Screened
Fertility Policy 1 SUMMARY This policy is intended to support individuals and couples who want to become parents but who have a possible pathological problem (physical or psychological) leading to them
Fertility Facts and Figures 2008
Fertility Facts and Figures 2008 Contents About these statistics... 2 Accessing our data... 2 The scale of fertility problems... 3 Treatment abroad... 3 Contacts regarding this publication... 3 Latest
The relevant NICE Clinical Guidance 156, Fertility can be accessed here: http://www.nice.org.uk/guidance/cg156
City and Hackney CCG Fertility policy Approved January 2015 Introduction City and Hackney CCG is responsible for commissioning a range of health services including hospital, mental health and community
Infertility: Advances in evidence-based research for consumers, payers and employers
Infertility: Advances in evidence-based research for consumers, payers and employers Evidence-based infertility treatment increases success rates and reduces costs. Page 1 For many couples facing infertility,
Tower Hamlets CCG Fertility policy
Tower Hamlets CCG Fertility policy Approved December 2014 Introduction Tower Hamlets CCG is responsible for commissioning a range of health services including hospital, mental health and community services
Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups
Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups File name: Infertility Services File code: UM.REPRO.01 Last Review: 02/2016
European IVF Monitoring (EIM) Year: 2010
European IVF Monitoring (EIM) Year: 2010 Name of country: Poland Name and full address of contact person: Professor Rafal Kurzawa, MD PhD Fertility and Sterility Special Interest Group Polish Gynaecological
Clinical Policy Committee
Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment
AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG. www.hopefertilitycenter.com www.hopeivf.com
Page 1 of 6 AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG. www.hopefertilitycenter.com www.hopeivf.com Age has a profound effect on female fertility. This is common knowledge,
Veljko Vlaisavljević. Overview
21.January 2010, ESHRE Campus Maribor Day 2-3 versus Day 5 transfer advantages and disadvantages Veljko Vlaisavljević Department of Reproductive Medicine and Gynecologic Endocrinology University Clinical
Transitioning from IVF practice to restorative reproductive medicine.
Transitioning from IVF practice to restorative reproductive medicine. Tadeusz Wasilewski Białystok Białystok Medical University in Branicki Palace - town of the first in vitro in Poland Cathedral - Divine
Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy
Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA Table of Contents 1.
Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY
Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY Dr Niel Senewirathne Senior Consultant of Obstetrician & Gynaecologist De zoyza Maternity Hospita 1 ART - IVF & ICSI 2 Infertility No pregnancy
FERTILITY AND AGE. Introduction. Fertility in the later 30's and 40's. Am I fertile?
FERTILITY AND AGE Introduction Delaying pregnancy is a common choice for women in today's society. The number of women in their late 30s and 40s attempting pregnancy and having babies has increased in
NWL CSU IFR Team CLINICAL COMMISSIONING GROUP BRIEFING. UPDATE OF THE PPwT POLICY ON IN-VITRO FERTILISATION (IVF)
NWL CSU IFR Team CLINICAL COMMISSIONING GROUP BRIEFING UPDATE OF THE PPwT POLICY ON IN-VITRO FERTILISATION (IVF) NWL CSU- PPwT Version 3 update- IVF Page 1 of 9 1. INTRODUCTION The NHS NWL policy on access
Endocrinology of the Female Reproductive Axis
Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN
How To Get A Refund On An Ivf Cycle
100% IVF Refund Program Community Hospital North Clearvista Dr. N Dr. David Carnovale and Dr. Jeffrey Boldt, along with everyone at Community Reproductive Endocrinology, are committed to providing you
Assisted Conception Policy. February 2016. Dr. Liz Saunders Cyril Haessig
Assisted Conception Policy February 2016 Dr. Liz Saunders Cyril Haessig CONTENTS Executive Summary... 3 Policy outline... 5 Detailed criteria... 8-2 - ASSISTED CONCEPTION COMMISSIONING POLICY EXECUTIVE
Carol Ludowese, MS, CGC Certified Genetic Counselor HDSA Center of Excellence at Hennepin County Medical Center Minneapolis, Minnesota
Carol Ludowese, MS, CGC Certified Genetic Counselor HDSA Center of Excellence at Hennepin County Medical Center Minneapolis, Minnesota The information provided by speakers in workshops, forums, sharing/networking
How to choose an IVF clinic and understand success rates: Questions to ask when choosing an IVF clinic.
Australia s National Infertility Network How to choose an IVF clinic and understand success rates: Questions to ask when choosing an IVF clinic. updated 26 05 2015 20 The information contained here is
Systematic review by: Dr. Ashraf Ahmed ElDaly, M.Sc., M.D.
Role of luteinizing hormone supplementation in the follicular phase and pregnancy, during controlled ovarian hyperstimulation in in vitro fertilization Systematic review by: Dr. Ashraf Ahmed ElDaly, M.Sc.,
Topic: Male Factor Infertility
Topic: Male Factor Infertility Topic Overview: Male Factor Infertility Comparisons of pregnancy rates at insemination based on total motile sperm counts from the 1999 and 21 World Health Organization (WHO)
Patient Information - Endometrial Scratch
Endo Scratch Royal Devon and Exeter NHS Foundation Trust Patient Information - Endometrial Scratch Why haven t we fallen pregnant with IVF? The chance of IVF being successful and resulting in a live birth
The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments Sykes D, Out H J, Palmer S J, van Loon J
The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments Sykes D, Out H J, Palmer S J, van Loon J Record Status This is a critical abstract of an economic evaluation that
Midland Fertility Services Blastocyst Transfer
Midland Fertility Services Blastocyst Transfer Building futures, transforming lives What is a blastocyst? When a sperm fertilises an egg the resulting embryo develops from the original single cell into
IVF SUCCESS RATES. Cancellation Rates. Under Age 35: 0% cancellations, national average 7.1% Age 35 37: 2.0% cancellations national average 10.
IVF SUCCESS RATES Program for Asst. Reproduction at Carolinas Medical Center, Charlotte, NC Number of ART cycles and transfers in 2009: 249 42.5 % 41.4 % 38.5 % 31.7 % Started 80 IVF cycles resulting in
Money-back guarantee,
Money-back IVF guarantees: weighing the pros and cons By David Adamson, MD IVF refund programs have been around for more than a decade and patients seem to like them. But critics question whether such
Reduced Ovarian Reserve Is there any hope for a bad egg?
Reduced Ovarian Reserve Is there any hope for a bad egg? Dr. Phil Boyle Galway Clinic, 19 th March 2014 For more information on Low AMH see www.napro.ie Anti Mullerian Hormone AMH levels are commonly measured
Metformin treatment before IVF / ICSI in non obese PCOS women
Metformin treatment before IVF / ICSI in non obese PCOS women A Nordic, prospective, randomised, double blind, multicentre study Sigrun Kjøtrød University Hospital of Trondheim, Norway Metformin effects
OHTAC Recommendation. In Vitro Fertilization and Multiple Pregnancies
OHTAC Recommendation In Vitro Fertilization and Multiple Pregnancies October 19, 2006 The Ontario Health Technology Advisory Committee (OHTAC) met on October 19, 2006 and reviewed the health technology
Drug Therapy Guidelines: Injectable Fertility Medications
Drug Therapy Guidelines: Injectable Fertility Medications Effective Date: 11/20/07 Committee Review Date: 7/12/00, 5/8/01, 1/15/02, 5/6/0, 12/16/0, 6/8/04, 12/16/05, 2/1/06, 10/15/06, 7/20/07, 11/5/07
Risks and complications of assisted conception
Risks and complications of assisted conception August 005 Richard Kennedy British Fertility Society Factsheet www.fertility.org.uk No medical treatment is entirely free from risk and infertility treatment
Assisted reproductive technologies (ARTs): Evaluation of evidence to support public policy development
Nardelli et al. Reproductive Health 2014, 11:76 REVIEW Open Access Assisted reproductive technologies (ARTs): Evaluation of evidence to support public policy development Alexa A Nardelli 1*, Tania Stafinski
Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection
Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection Sandra L. Emmons, MD Phillip Patton, MD Source: Medical Acupuncture, A Journal For Physicians By Physicians Spring
Egg and sperm donation in the UK: 2012 2013
Egg and sperm donation in the UK: 2012 2013 Contents Introduction 2 Background to this report 2 Terms and acronyms used in this report 4 Methodology 5 How we gathered the data 5 Understanding the data
Assisted Reproductive Technologies at IGO
9339 Genesee Avenue, Suite 220 San Diego, CA 92121 858 455 7520 Assisted Reproductive Technologies at IGO Although IGO no longer operates an IVF laboratory or program as such, we work closely with area
Report to Congress Efforts to Treat Infertility of Military Families
Report to Congress Efforts to Treat Infertility of Military Families Office of the Secretary of Defense December 2015 The estimated cost of report or study for the Department of Defense is approximately
IVF OVERVIEW. Tracy Telles, M.D.
IVF OVERVIEW By Tracy Telles, M.D. Dr. Hendler: Hello and welcome to KP Healthcast. I m your host Dr. Peter Hendler and today our guest is Dr. Tracy Telles. Dr. Telles is an IVF physician in Kaiser Walnut
REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN 55125 (651) 222-6050
REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN 55125 (651) 222-6050 RECIPIENT COUPLE INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION
Lesbian Pregnancy: Donor Insemination
Lesbian Pregnancy: Donor Insemination (Based on an article originally published in the American Fertility Association 2010 National Fertility and Adoption Directory. Much of this information will also
London Fertility Centre Price List
London Fertility Centre Price List Fertility Testing Packages Standard Female fertility testing package AMH Ultrasound scan 15 minute doctor consultation to discuss your results Premium Female fertility
Can In Vitro Fertilization enhance fertility in Europe? A scenario study
Can In Vitro Fertilization enhance fertility in Europe? A scenario study Gijs Beets 3 On behalf of Egbert te Velde 4, J. Dik F. Habbema 1, Marinus J.C. Eijkemans 1, and Geeta Nargund 2 1 Department of
Endometriosis & Infertility& Treatments. A. Musa Zamah, MD, PhD
Endometriosis & Infertility& Treatments A. Musa Zamah, MD, PhD Full Disclosure of Faculty Financial Interests or Relationships I agree to follow the UIC and ACCME policies and declare that I do not have
Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care
Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
University Hospitals Coventry and Warwickshire NHS Trust. Centre for Reproductive Medicine. We Care. We Achieve. We Innovate.
University Hospitals Coventry and Warwickshire NHS Trust Centre for Reproductive Medicine We Care. We Achieve. We Innovate. Introduction We were the first NHS Hospital in the West Midlands to set up a
Ehlers-Danlos Syndrome Fertility Issues. Objectives
Ehlers-Danlos Syndrome Fertility Issues Baltimore Inner Harbor Independence Day Brad Hurst, M.D. Professor Reproductive Endocrinology Carolinas Medical Center - Charlotte, North Carolina Objectives Determine
Consent to Perform Preimplantation Genetic Screening (PGS) using. Comparative Genomic Hybridization (acgh) or Next Generation Sequencing (NGS)
Consent to Perform Preimplantation Genetic Screening (PGS) using Array Comparative Genomic Hybridization (acgh ) or Next Generation Sequencing (NGS) Purpose The purpose of Preimplantation Genetic Screening
Assisted reproductive technology in Australia and New Zealand 2010
Assisted reproductive technology in Australia and New Zealand 2010 ASSISTED REPRODUCTION SERIES Number 16 Assisted reproductive technology in Australia and New Zealand 2010 Alan Macaldowie Yueping A Wang
Rationale for replacing IVIG with Intralipid (IL) for immunological pregnancy loss
Rationale for replacing IVIG with Intralipid (IL) for immunological pregnancy loss Recurrent Pregnancy Loss The reason that an embryo may not implant successfully is either because there is something intrinsically
The best possible start to life
The best possible start to life April 2007 A consultation document on multiple births after IVF Chair s foreword My main concern as Chair of the Human Fertilisation and Embryology Authority is probably
CONSENT TO PARTICIPATE IN THE IN VITRO FERTILIZATION-EMBRYO TRANSFER PROGRAM
CONSENT TO PARTICIPATE IN THE IN VITRO FERTILIZATION-EMBRYO TRANSFER PROGRAM I, after consultation with my physician, request to participate in the In Vitro Fertilization (IVF)-Embryo Transfer (ET) procedures
East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception. December 2014
East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception December 2014 1 1. Introduction This policy sets out the entitlement and service that will
Project proposal. Reproductive tourism in India: A description of surrogate mothers and their offspring. Medical student Malene Tanderup Kristensen
Project proposal Reproductive tourism in India: A description of surrogate mothers and their offspring Background Medical student Malene Tanderup Kristensen Traditional surrogacy is defined as where the
obstetric and gynecology department on two sub-specialty services: maternal fetal medicine
Obstetrics and Gynecology in New Zealand Kelsey Simpson, MS4 During my time in New Zealand, I had the opportunity to integrate myself into the obstetric and gynecology department on two sub-specialty services:
Etienne Van den Abbeel
Optimized i scoring at blastocyst t stage ESHRE SIG Embryology Course, Practical aspects of non-invasive selection of gametes, embryos and blastocysts in a modern IVF laboratory, Salzburg, 2011. Etienne
Recent Progress in In Vitro Fertilization and Intracytoplasmic Sperm Injection Technologies in Japan
Research and Reviews Recent Progress in In Vitro Fertilization and Intracytoplasmic Sperm Injection Technologies in Japan JMAJ 52(1): 29 33, 2009 Kaoru YANAGIDA* 1 Abstract The three basic pillars of fertility
Research Article Association of ABO Blood Type and Ovarian Stimulation Response in Oocyte Donors
Cronicon OPEN ACCESS Nigel Pereira 1 *, Anne P Hutchinson 2, Jovana P Lekovich 1, Rony T Elias 1, Zev Rosenwaks 1 and Steven D Spandorfer 1 1 Ronald O Perelman and Claudia Cohen Center for Reproductive
Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in Cases of Habitual Abortions
Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in * (MBChB, FICMS, CABOG) **Sawsan Talib Salman (MBChB, FICMS, CABOG) ***Huda Khaleel Ibrahim (MBChB) Abstract Background: - Although
Age and Fertility. A Guide for Patients PATIENT INFORMATION SERIES
Age and Fertility A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the Patient Education Committee and the Publications
INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES
INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES We, the undersigned, as patient and partner understand that we will be undergoing one or more procedures
COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY
COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY Policy: Infertility Evaluation and Treatment Number: MM 1306 Date Effective:
Fertility Treatment Cost
Fertility Treatment Cost Background Understanding Infertility Infertility is generally defined as the inability to conceive after 1 year of properly timed unprotected intercourse. Fertility problems affect
SO, WHAT IS A POOR RESPONDER?
SO, WHAT IS A POOR RESPONDER? We now understand why ovarian reserve is important and how we assess it, but how is poor response defined? Unfortunately, there is no universally accepted definition for the
30% Off Cycle 1. Possible Preliminary Discussions With Contract Negotiations
Specialists In Reproductive Medicine & Surgery, P.A. www.dreamababy.com [email protected] Excellence, Experience & Ethics Gestational Surrogacy Price List (2015) We here at Specialists in Reproductive
Fertility-related choices. A decision aid for younger women with early breast cancer
Fertility-related choices A decision aid for younger women with early breast cancer Fertility-related choices Section 1 About this booklet 1 Overview 3 Summary of fertility options 4 Section 2 Some background
Artificial insemination with donor sperm
Artificial insemination with donor sperm Ref. 123 / 2009 Reproductive Medicine Unit Servicio de Medicina de la Reproducción Gran Vía Carlos III 71-75 08028 Barcelona Tel. (+34) 93 227 47 00 Fax. (+34)
IVF MONEY-BACK PLAN IN PARTNERSHIP WITH
IVF MONEY-BACK PLAN IN PARTNERSHIP WITH Programmes Refund Programme Up to 3 fresh cycles of IVF/ICSI and all frozen embryo transfers Available to women under 40 years old Medical Review required for all
IN VITRO FERTILISATION IVF and ICSI
IN VITRO FERTILISATION IVF and ICSI Page 1 of 7 WHAT ARE IVF and ICSI? IVF is short for in vitro fertilisation which means fertilisation outside the body. It usually involves stimulation of the ovaries
Fertility care for women diagnosed with cancer
Saint Mary s Hospital Department of Reproductive Medicine Fertility care for women diagnosed with cancer Information For Patients INF/DRM/NUR/16 V1/01/11/2013 1 2 Contents Page Overview 4 Our Service 4
Management of low grade glioma s: update on recent trials
Management of low grade glioma s: update on recent trials M.J. van den Bent The Brain Tumor Center at Erasmus MC Cancer Center Rotterdam, the Netherlands Low grades Female, born 1976 1 st seizure 2005,
IVF Waiting Times in Scotland
IVF Waiting Times in Scotland Quarter ending 31 March 2016 Publication date 31 May 2016 An Official Statistics Publication for Scotland Key Points The Scottish Government have set a target that at least
Outline. Objective(s) Background. Methods. Results. Discussion. Questions
Outline Objective(s) Background Methods Results Discussion Questions Objectives To evaluate if psychological stress varies with the phase of in vitro fertilization treatment To determine if socio-demographic
Management fertility sparing degli endometriomi Errico Zupi
Management fertility sparing degli endometriomi Errico Zupi Università Tor Vergata Roma Management of endometrioma Pain Infertility Surgical treatment Medical treatment Infertility clinic Both medical
in vitro Fertilization (IVF)
Should an age limit be imposed on in vitro fertilization? Amanda Caster, Rong Hu, John Brothers II, and Barry Sexton Bioengineering and Bioinformatics Summer Institute 2005 University of Pittsburgh, Carnegie
The objectives of this chapter are: To provide an understanding of the various stimulation protocols used in IVF To enable the student to understand
1 The objectives of this chapter are: To provide an understanding of the various stimulation protocols used in IVF To enable the student to understand the factors affecting the choice of protocol based
The position of hysteroscopy in current fertility practice is under debate.
The position of hysteroscopy in current fertility practice is under debate. The procedure is well tolerated. No consensus on effectiveness of HSC in improving prognosis of subfertile women. systematic
Preimplantation genetic screening (PGS)
Preimplantation genetic screening (PGS) Dagan Wells Reprogenetics UK In vitro fertilization (IVF) A highly successful medical intervention Infertility treatment revolutionized Estimated that >5 million
Assisted Conception Unit, St James' University Hospital - Leeds
Assisted Conception Unit, St James' University Hospital - Leeds Contact details Level 6, Gledhow Wing, St James' University Hospital, Beckett Street, Leeds, LS9 7TF Phone: Fax: Web: 113 26 5387 113 26
Preimplantation Genetic Diagnosis. Evaluation for single gene disorders
Preimplantation Genetic Diagnosis Evaluation for single gene disorders What is Preimplantation Genetic Diagnosis? Preimplantation genetic diagnosis or PGD is a technology that allows genetic testing of
Introduction. Materials and Methods
POSTPARTUM OVULATION By Konald A. Prem, M.D. Professor, Department of Obstetrics and Gynecology University of Minnesota Medical School Paper presented at the 1971 La Leche League Convention in Chicago
FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES
FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES Niteesh K. Choudhry, MD, PhD Harvard Medical School Division of Pharmacoepidemiology and Pharmacoeconomics
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics. January 2006
Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics January 2006 1. BACKGROUND ICSI has been shown to be effective for male factor infertility and it also
HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION
CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION Protocol Title: A5322, Version 2.0, 01/28/15 Long-term Follow-up of Older HIV-infected Adults in the ACTG: Addressing
Frequently Asked Questions
What does the product do? The Stork by Rinovum Women s Health bridges the gap between natural intercourse and more aggressive, costly treatments, like IUI or IVF. The Stork is a home conception kit that
